rs555421894
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_001329943.3(KIAA0586):c.94dupC(p.His32ProfsTer8) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000621 in 1,613,896 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001329943.3 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KIAA0586 | NM_001329943.3 | c.94dupC | p.His32ProfsTer8 | frameshift_variant | Exon 1 of 31 | ENST00000652326.2 | NP_001316872.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KIAA0586 | ENST00000652326.2 | c.94dupC | p.His32ProfsTer8 | frameshift_variant | Exon 1 of 31 | NM_001329943.3 | ENSP00000498929.1 |
Frequencies
GnomAD3 genomes AF: 0.000552 AC: 84AN: 152116Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000285 AC: 71AN: 249262Hom.: 0 AF XY: 0.000348 AC XY: 47AN XY: 135234
GnomAD4 exome AF: 0.000628 AC: 918AN: 1461662Hom.: 1 Cov.: 32 AF XY: 0.000609 AC XY: 443AN XY: 727118
GnomAD4 genome AF: 0.000552 AC: 84AN: 152234Hom.: 0 Cov.: 32 AF XY: 0.000510 AC XY: 38AN XY: 74438
ClinVar
Submissions by phenotype
not provided Pathogenic:4
- -
- -
- -
Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 26096313, 28497568, 26386044, 27535533) -
Joubert syndrome 23;C4225286:Short-rib thoracic dysplasia 14 with polydactyly Pathogenic:1Other:1
Variant interpreted as Likely pathogenic and reported on 07-21-2021 by Lab or GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -
This sequence change creates a premature translational stop signal (p.His44Profs*8) in the KIAA0586 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in KIAA0586 are known to be pathogenic (PMID: 26096313, 26166481, 26386044). This variant is present in population databases (rs555421894, gnomAD 0.04%). This premature translational stop signal has been observed in individual(s) with features of both Joubert syndrome and Jeune asphyxiating thoracic dystrophy and Joubert syndrome (PMID: 26096313, 26386044). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 445497). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Neurodevelopmental disorder Pathogenic:1
- -
Joubert syndrome and related disorders Pathogenic:1
Variant summary: KIAA0586 c.130dupC (p.His44ProfsX8) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 0.00028 in 249262 control chromosomes. c.130dupC has been reported in the literature in individuals affected with Joubert Syndrome And Related Disorders, including at least one individual with a compound heterozygous genotype (e.g. Summers_2017). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 28497568). Eight submitters have cited clinical-significance assessments for this variant to ClinVar after 2014, classifying the variant as pathogenic (n=4), likely pathogenic (n=3), or uncertain significance (n=1). Based on the evidence outlined above, the variant was classified as pathogenic. -
Joubert syndrome 23 Pathogenic:1
- -
KIAA0586-related disorder Pathogenic:1
The KIAA0586 c.130dupC variant is predicted to result in a frameshift and premature protein termination (p.His44Profs*8). This variant (also known as c.94dup in an alternate transcript) has been reported to be causative for autosomal recessive Joubert syndrome (Bachmann-Gagescu et al. 2015. PubMed ID: 26096313; Table S2 - Summers et al. 2017. PubMed ID: 28497568). This variant is reported in 0.045% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/14-58895075-T-TC). Frameshift variants in KIAA0586 are expected to be pathogenic and this variant has been classified as pathogenic or likely pathogenic by multiple independent submitters to the ClinVar database (https://www.ncbi.nlm.nih.gov/clinvar/variation/445497). This variant is interpreted as pathogenic. -
Retinal dystrophy Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at